Evidence map›Paper›PMID 35545564›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[A real-world study of the efficacy and safety of sofosbuvir and velpatasvir in the treatment of HCV-infected patients in a county in northern China].

L X Qiu, H B Yu, W Lin, Y R Liu, Y D Qiu, Z J Hu, X H Pang, J Zhang, Y L Liu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

L X QiuThe Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
H B YuThe Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
W LinThe Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y R LiuThe Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y D QiuGeneral Hospital of Gu'an County, Langfang City, Hebei 065500, China.
Z J HuThe Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
X H PangBeijing Center for Disease Control and Prevention, Beijing 100013, China.
J ZhangThe Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Y L LiuThe Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Capital Medical University · CNBeijing Center for Disease Prevention and Control · CNHospital of Hebei Province · CN

Funding

Capital Health Development Fund 2020-1-3011National Science and Technology Major Project 2017ZX10202202-005-010Youan Liver Disease and AIDS Fund YNKTTS20180105, PX2018058, PX2022066
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis CHepatitis C, ChronicAntiviral AgentsBenzimidazolesBenzopyransCarbamatesDrug Therapy, CombinationGenotypeHepacivirusHeterocyclic Compounds, 4 or More RingsHumansLiver CirrhosisProspective StudiesRibavirinRNASofosbuvirAntiviral AgentsBenzimidazolesBenzopyransCarbamatesHeterocyclic Compounds, 4 or More RingsRibavirinRNASofosbuvirvelpatasvir

Identifiers

PMID35545564
PMCPMC12769980
OpenAlexW4280538140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.